|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.37 USD | -12.60% |
|
-36.32% | -64.58% |
Applied DNA Sciences, Inc. reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported revenue was USD 0.891164 million compared to USD 5.26 million a year ago. Net loss was USD 1.11 million compared to USD 3.84 million a year ago.
Basic loss per share from continuing operations was USD 1.8 compared to USD 6 a year ago. Diluted loss per share from continuing operations was USD 1.8 compared to USD 6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -64.58% | 3.77M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B |
APPLIED DNA SCIENCES, INC. 
